ESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
ESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), ...
Xeris Biopharma is showing strong growth and improving EBITDA, especially driven by its blockbuster drug Recorlev. Learn why ...
Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine ...
A spike in M&A activity and stock prices have pulled biotech out of a yearslong downturn. But regulatory tumult and fierce ...
Fintel on MSN
Mereo BioPharma Group plc - Depositary receipt (MREO) price target decreased by 16.00% to 1.78
The average one-year price target for Mereo BioPharma Group plc - Depositary Receipt (NasdaqCM:MREO) has been revised to ...
Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of ...
Q3 2026 Management View Brian Tyler, CEO & Director, emphasized the company's continued momentum in oncology, biopharma services, and North American distribution, stating, "Revenue and adjusted EPS ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) ('Propanc” or the 'Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...
With the biopharma industry performing better of late, analysts, executives and other industry watchers are “cautiously ...
Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...
India’s Biopharma Shakti initiative announced in the Union Budget 2026 marks a clear shift towards patient-centric healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results